Dusina, Alex
 Distribuzione geografica
Continente #
NA - Nord America 795
AS - Asia 559
EU - Europa 506
SA - Sud America 120
AF - Africa 19
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.004
Nazione #
US - Stati Uniti d'America 758
SG - Singapore 288
IT - Italia 110
CN - Cina 107
BR - Brasile 103
SE - Svezia 102
FR - Francia 67
DE - Germania 62
VN - Vietnam 42
FI - Finlandia 38
GB - Regno Unito 31
IE - Irlanda 28
CA - Canada 23
IN - India 23
ID - Indonesia 20
JP - Giappone 20
HK - Hong Kong 15
PL - Polonia 14
ZA - Sudafrica 11
RU - Federazione Russa 10
AR - Argentina 9
BD - Bangladesh 9
MX - Messico 9
ES - Italia 8
AT - Austria 7
LT - Lituania 6
PK - Pakistan 5
BE - Belgio 4
CI - Costa d'Avorio 4
NL - Olanda 4
UZ - Uzbekistan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
IQ - Iraq 3
IR - Iran 3
RO - Romania 3
TR - Turchia 3
AU - Australia 2
MA - Marocco 2
MD - Moldavia 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
GT - Guatemala 1
KE - Kenya 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
Totale 2.004
Città #
Singapore 165
Chandler 163
Ashburn 86
San Jose 73
Milan 45
Beijing 37
New York 36
Helsinki 33
Rome 32
Dublin 26
Los Angeles 22
Lauterbourg 20
Frankfurt am Main 19
Tokyo 19
Boston 17
Jakarta 17
San Mateo 17
Princeton 16
Hanoi 14
Ho Chi Minh City 13
Marseille 13
Montreal 13
Warsaw 13
Hong Kong 12
Munich 12
Wilmington 11
Dallas 10
São Paulo 9
Brooklyn 8
Chicago 8
Johannesburg 8
London 8
Nuremberg 8
St Louis 8
Düsseldorf 7
Orem 7
Hefei 6
Paris 6
Pune 6
Santa Clara 6
Seattle 6
The Dalles 6
Vienna 6
Moscow 5
Redwood City 5
Stockholm 5
Abidjan 4
Atlanta 4
Brussels 4
Chennai 4
Council Bluffs 4
Haiphong 4
Manchester 4
Mexico City 4
Rosario 4
Tashkent 4
Tianjin 4
Toronto 4
Turku 4
Andover 3
Bologna 3
Bremen 3
Cambridge 3
City of London 3
Dhaka 3
Fairfield 3
Falkenstein 3
Houston 3
Lahore 3
Nanjing 3
Phoenix 3
Poplar 3
Roubaix 3
San Francisco 3
Woodbridge 3
Abu Dhabi 2
Amsterdam 2
Augusta 2
Baku 2
Bexley 2
Brescia 2
Buffalo 2
Calgary 2
Capannori 2
Cape Town 2
Carapicuíba 2
Concord 2
Curitiba 2
Dearborn 2
Denver 2
Edinburgh 2
Franca 2
Genoa 2
Guangzhou 2
Hortolândia 2
Las Vegas 2
Lisbon 2
Madrid 2
Norwalk 2
Ottawa 2
Totale 1.232
Nome #
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 157
Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 148
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir–rilpivirine in clinical practice 148
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 147
Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database 136
Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice 136
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 136
Efficacy and safety of raltegravir in switch strategies in virologically suppressed patients: long-term data from clinical practice 128
Short Communication: Comparing Lamivudine+Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as Switch Strategies: Preliminary Results from Clinical Practice 121
SARS-CoV-2 infection in a highly experienced person living with HIV 117
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 116
Risk of Tumor Onset in HIV+ Patients on Two-Drug Regimens: A Cohort Study in an Italian Hospital 108
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic 102
Virological outcomes with dolutegravir plus either lamivudine or two NRTIs as switch strategies: a multi-cohort study 98
Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients during Lamivudine plus Dolutegravir Maintenance Therapy in Clinical Practice 82
Short Communication: Efficacy and Safety of Dolutegravir plus Lamivudine as a First-Line Regimen in Clinical Practice 82
No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir 71
Totale 2.033
Categoria #
all - tutte 9.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.101


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 4 5
2021/2022114 1 1 0 7 0 2 10 22 5 5 15 46
2022/2023412 49 62 19 60 33 45 22 46 45 4 26 1
2023/2024193 13 40 0 17 8 34 15 6 5 9 27 19
2024/2025408 8 4 59 14 40 31 17 14 62 37 71 51
2025/2026846 129 13 48 109 224 49 121 39 53 60 1 0
Totale 2.033